Jun 24
For one thing, the pharmaceutical companies have to pay for all that lobbying effort. Getting Congress to do your bidding does not come cheap.
The Wall Street Journal reports on a Center for Public Integrity report that the pharmaceutical industry spent $168 million lobbying Congress in 2007, up 32 percent from the previous year.